Interstitial Lung Disease Associated with Chronic Nitrofurantoin Use
Fuente:
Zenodo
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Recurso digital |
| Langue: | anglo-saxon (environ 450-1100), ancien anglais |
| Publié: |
Zenodo
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866902294141861888 |
|---|---|
| author | Erick Jafet González Roblero Karla Fabiola Aguirre avila Erika Patricia Cerna Alcantar Elizabeth Arellano Pacheco Diana Karen Fernández López Hannia Sarali Mares Cárdenas Roberto Teutli Pérez Jesús Arturo Portillo Ibarra Mirtha Saavedra Vazquez |
| author_facet | Erick Jafet González Roblero Karla Fabiola Aguirre avila Erika Patricia Cerna Alcantar Elizabeth Arellano Pacheco Diana Karen Fernández López Hannia Sarali Mares Cárdenas Roberto Teutli Pérez Jesús Arturo Portillo Ibarra Mirtha Saavedra Vazquez |
| contents | <p><strong>Introduction: </strong>Since 2011, nitrofurantoin has been reconsidered as a first-line treatment, but it can cause rare pulmonary and liver toxicity. Chronic use can lead to interstitial lung disease (ILD). The case presented highlights the suspicion of ILD in patients with respiratory symptoms after prolonged nitrofurantoin use.</p> <p><strong>Case presentation: </strong>A 64-year-old woman receiving nitrofurantoin long-term developed severe pulmonary symptoms. After ruling out infections and autoimmune diseases, pulmonary toxicity was suspected. Treatment produced significant improvement, and she was discharged, continuing therapy and discontinuing nitrofurantoin.</p> <p><strong>Conclusion: </strong>Nitrofurantoin toxicity is underreported in Mexico. Despite being safe, prolonged use can cause serious effects, so regular follow-up is essential.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_15401215 |
| institution | Zenodo |
| language | ang |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Interstitial Lung Disease Associated with Chronic Nitrofurantoin Use Erick Jafet González Roblero Karla Fabiola Aguirre avila Erika Patricia Cerna Alcantar Elizabeth Arellano Pacheco Diana Karen Fernández López Hannia Sarali Mares Cárdenas Roberto Teutli Pérez Jesús Arturo Portillo Ibarra Mirtha Saavedra Vazquez Nitrofurantoin, Interstitial lung disease, Pulmonary fibrosis, Urinary tract infections, Adverse reaction to medications. <p><strong>Introduction: </strong>Since 2011, nitrofurantoin has been reconsidered as a first-line treatment, but it can cause rare pulmonary and liver toxicity. Chronic use can lead to interstitial lung disease (ILD). The case presented highlights the suspicion of ILD in patients with respiratory symptoms after prolonged nitrofurantoin use.</p> <p><strong>Case presentation: </strong>A 64-year-old woman receiving nitrofurantoin long-term developed severe pulmonary symptoms. After ruling out infections and autoimmune diseases, pulmonary toxicity was suspected. Treatment produced significant improvement, and she was discharged, continuing therapy and discontinuing nitrofurantoin.</p> <p><strong>Conclusion: </strong>Nitrofurantoin toxicity is underreported in Mexico. Despite being safe, prolonged use can cause serious effects, so regular follow-up is essential.</p> |
| title | Interstitial Lung Disease Associated with Chronic Nitrofurantoin Use |
| topic | Nitrofurantoin, Interstitial lung disease, Pulmonary fibrosis, Urinary tract infections, Adverse reaction to medications. |
| url | https://doi.org/10.5281/zenodo.15401215 |